Log In
BCIQ
Print this Print this
 

Flammazine

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
DescriptionSilver sufadiazine cream
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Infectious (unspecified)
Indication DetailsTreat and prevent infections in burn wounds
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$25.7M

$25.7M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/30/2011

Undisclosed

Undisclosed

Undisclosed

10/19/2009

$25.7M

$25.7M

0

Get a free BioCentury trial today